Company Background
Nanobiosym® was founded to create breakthrough scientific insights and
revolutionary technologies that emerge from the convergence of physics, nanotechnology,
and biomedicine.
Nanobiosym® (NBS) works symbiotically with our commercial partner Nanobiosym®
Diagnostics (NBSDx) to discover, develop, and commercialize breakthrough technologies
at this interface. NBSDx is currently developing nanobiotechnology platforms
that address global healthcare needs.
